FDA issues letter to Procter & Gamble regarding manufacturing plant conditions
ROCKVILLE, Md. The Food and Drug Administration late last month issued a warning letter to Procter & Gamble regarding unsanitary conditions at a plant in Puerto Rico that manufacturers Sinex Long Acting Nasal Spray and Vicks Early Defense Hand Sanitizer as well as several Olay hair care and skin care products.
The warning letter suggested that problems at the plant may have caused contamination or threatened the health of consumers and faulted failures in following procedures for cleaning maintenance equipment.
P&G said none of the issues raised by the FDA compromised the safety of any products, according to an AP report. Paul Fox, P&G spokesman, told the news service that FDA inspectors did identify areas “here we can and will make improvements,” and the company has begun a review of the plant’s manufacturing practices.
Energizer Personal Care donates antibacterial wipes to swine flu-infected communities
SHELTON, Conn. Energizer Personal Care has announced that it will donate 500,000 packages of Wet Ones Antibacterial Wipes to schools in communities hardest hit by the swine flu, as well as offer coupons for the wipes online.
Wet Ones, which is a trademark of Energizer’s Playtex Products, can help keep hands clean when on the go as they promise to kill 99.99% of germs and clean hands by removing dirt and grime. According to the company, hand sanitizer gels just kill germs.
“While frequent washing hands with soap and water are always recommended, the reality of busy lives is that there are times when you just can’t get to a sink,” stated Charles Slife, VP research and development at Energizer Personal Care. “A product like Wet Ones Antibacterial Wipes that can help keep hands clean and germ-free will help parents and kids alike stay healthy when soap and water are not available.”
In addition to donating packages of wipes, Energizer Personal Care will also make $1 off coupons for Wet Ones Antibacterial Wipes available online at www.wetones.com. The site will also include tips on how people can stay healthy.
Beauty treatment gets enhanced warning from FDA
ROCKVILLE, Md. A popular beauty treatment will get an enhanced warning from the Food and Drug Administration following reports of serious side effects, the FDA announced Thursday.
The agency said that all botulinum toxin products, used to eliminate wrinkles and treat muscle spasticity from the skin, will get a boxed warning and be subject to a risk evaluation and mitigation strategy.
The FDA’s action follows reports that the toxin may spread from the area of injection to other parts of the body, resulting in symptoms similar to botulism. These include loss of strength and muscle weakness, difficulty speaking, loss of bladder control, vision problems and trouble breathing. Most of the symptoms have been reported in children with cerebral palsy receiving botulin toxin for muscle spasticity.
Products affected include Allergan’s Botox and Botox Cosmetic (botulinum toxin type A), Solstice Neurosciences’ Myobloc (botulinum toxin type B) and Ipsen Biopharm’s Dysport (abobotulinumtoxinA).